JP2014532751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532751A5 JP2014532751A5 JP2014540552A JP2014540552A JP2014532751A5 JP 2014532751 A5 JP2014532751 A5 JP 2014532751A5 JP 2014540552 A JP2014540552 A JP 2014540552A JP 2014540552 A JP2014540552 A JP 2014540552A JP 2014532751 A5 JP2014532751 A5 JP 2014532751A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- cancer
- der
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(CC1)CC1C(C)=C Chemical compound C*(CC1)CC1C(C)=C 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161557457P | 2011-11-09 | 2011-11-09 | |
| US61/557,457 | 2011-11-09 | ||
| PCT/GB2012/052786 WO2013068755A1 (en) | 2011-11-09 | 2012-11-09 | 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014532751A JP2014532751A (ja) | 2014-12-08 |
| JP2014532751A5 true JP2014532751A5 (OSRAM) | 2015-12-10 |
| JP6073910B2 JP6073910B2 (ja) | 2017-02-01 |
Family
ID=47178213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540552A Active JP6073910B2 (ja) | 2011-11-09 | 2012-11-09 | ５−（ピリジン−２−イル−アミノ）−ピラジン−２−カルボニトリル化合物及びその治療使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9040540B2 (OSRAM) |
| EP (1) | EP2776417B1 (OSRAM) |
| JP (1) | JP6073910B2 (OSRAM) |
| CN (1) | CN104105696B (OSRAM) |
| AU (1) | AU2012335409B2 (OSRAM) |
| BR (1) | BR112014010938A2 (OSRAM) |
| CA (1) | CA2849566C (OSRAM) |
| ES (1) | ES2709003T3 (OSRAM) |
| RU (1) | RU2641693C2 (OSRAM) |
| WO (1) | WO2013068755A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014010938A2 (pt) | 2011-11-09 | 2017-05-16 | Cancer Res Tech Ltd | compostos de 5-(piridin-2-il-amino)-pirazina-2-carbonitrila e seu uso terapêutico |
| PL2855448T3 (pl) | 2012-05-15 | 2017-09-29 | Cancer Research Technology Ltd | 5-[[4-[[morfolino-2-ilo]metyloamino]-5-(trifluorometylo)-2-pirydylo]amino]pirazyno-2-karbonitryl i jego zastosowanie terapeutyczne |
| CZ306322B6 (cs) | 2014-12-17 | 2016-11-30 | Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové | Substituovaný 2-(2-fenylhydrazinyl)pyrazin, způsob jeho přípravy, jeho použití a farmaceutický přípravek ho obsahující |
| JOP20180011A1 (ar) | 2017-02-16 | 2019-01-30 | Gilead Sciences Inc | مشتقات بيرولو [1، 2-b]بيريدازين |
| TWI842978B (zh) | 2018-07-13 | 2024-05-21 | 美商基利科學股份有限公司 | 衍生物 |
| CN110872277B (zh) * | 2019-11-14 | 2021-06-04 | 浙江大学 | N-取代芳环-2-氨基嘧啶类化合物及用途 |
| CN116917009A (zh) | 2021-02-19 | 2023-10-20 | 美国迈胜医疗系统有限公司 | 用于粒子治疗系统的机架 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773778A (en) | 1972-01-24 | 1973-11-20 | Squibb & Sons Inc | Sulfur derivatives of pyrazolo (3,4-b)pyridines |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| JP4146514B2 (ja) | 1995-07-06 | 2008-09-10 | ノバルティス アクチエンゲゼルシャフト | ピロロピリミジン類およびその製造方法 |
| US7271261B2 (en) | 2001-10-19 | 2007-09-18 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted benzimidazoles and imidazo-[4,5]-pyridines |
| EP1441725A1 (en) | 2001-10-26 | 2004-08-04 | Aventis Pharmaceuticals Inc. | Benzimidazoles and analogues and their use as protein kinases inhibitors |
| EP1442039A1 (en) | 2001-10-31 | 2004-08-04 | Bayer HealthCare AG | Pyrimido (4,5-b) indole derivatives |
| CA2484209C (en) | 2002-05-03 | 2013-06-11 | Exelixis, Inc. | Protein kinase modulators and methods of use |
| US7202244B2 (en) | 2002-05-29 | 2007-04-10 | Millennium Pharmaceuticals, Inc. | Chk-1 inhibitors |
| MXPA06001098A (es) | 2003-07-29 | 2006-04-24 | Irm Llc | Compuestos y composiciones utiles como inhibidores de proteina cinasa. |
| CA2542105C (en) | 2003-10-08 | 2011-08-02 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| CA2542076C (en) | 2003-10-14 | 2013-02-26 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Substituted tricyclic compounds as protein kinase inhibitors |
| CN1882345A (zh) | 2003-10-16 | 2006-12-20 | 希龙公司 | 作为raf激酶抑制剂以治疗癌症的2,6－二取代的喹唑啉、喹喔啉、喹啉和异喹啉 |
| US20050096324A1 (en) | 2003-11-05 | 2005-05-05 | Zhi-Fu Tao | Macrocyclic kinase inhibitors |
| US7163939B2 (en) | 2003-11-05 | 2007-01-16 | Abbott Laboratories | Macrocyclic kinase inhibitors |
| US7642354B2 (en) | 2004-04-13 | 2010-01-05 | Icagen, Inc. | Polycyclic pyrazines as potassium ion channel modulators |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| US20090029982A1 (en) | 2005-04-28 | 2009-01-29 | Supergen, Inc. | Protein kinase inhibitors |
| WO2007000240A1 (en) | 2005-06-28 | 2007-01-04 | Sanofi-Aventis | Isoquinoline derivatives as inhibitors of rho-kinase |
| TW200804345A (en) * | 2005-08-30 | 2008-01-16 | Novartis Ag | Substituted benzimidazoles and methods of preparation |
| US7776865B2 (en) | 2005-10-06 | 2010-08-17 | Schering Corporation | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| JP5405316B2 (ja) | 2006-12-27 | 2014-02-05 | サノフイ | シクロアルキルアミン置換イソキノリン誘導体 |
| ES2485040T3 (es) | 2007-03-16 | 2014-08-12 | The Scripps Research Institute | Inhibidores de cinasa de adhesión focal |
| WO2008117050A1 (en) | 2007-03-27 | 2008-10-02 | Astrazeneca Ab | Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer |
| US8618121B2 (en) | 2007-07-02 | 2013-12-31 | Cancer Research Technology Limited | 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors |
| GB0719644D0 (en) | 2007-10-05 | 2007-11-14 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| GB0803018D0 (en) * | 2008-02-19 | 2008-03-26 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| TW201512199A (zh) * | 2008-06-11 | 2015-04-01 | Genentech Inc | 二氮雜咔唑及使用方法 |
| BR112014010938A2 (pt) | 2011-11-09 | 2017-05-16 | Cancer Res Tech Ltd | compostos de 5-(piridin-2-il-amino)-pirazina-2-carbonitrila e seu uso terapêutico |
| PL2855448T3 (pl) | 2012-05-15 | 2017-09-29 | Cancer Research Technology Ltd | 5-[[4-[[morfolino-2-ilo]metyloamino]-5-(trifluorometylo)-2-pirydylo]amino]pirazyno-2-karbonitryl i jego zastosowanie terapeutyczne |
-
2012
- 2012-11-09 BR BR112014010938A patent/BR112014010938A2/pt not_active IP Right Cessation
- 2012-11-09 ES ES12784666T patent/ES2709003T3/es active Active
- 2012-11-09 EP EP12784666.5A patent/EP2776417B1/en active Active
- 2012-11-09 RU RU2014121334A patent/RU2641693C2/ru active
- 2012-11-09 CN CN201280055367.2A patent/CN104105696B/zh not_active Expired - Fee Related
- 2012-11-09 CA CA2849566A patent/CA2849566C/en active Active
- 2012-11-09 AU AU2012335409A patent/AU2012335409B2/en not_active Ceased
- 2012-11-09 WO PCT/GB2012/052786 patent/WO2013068755A1/en not_active Ceased
- 2012-11-09 US US14/356,626 patent/US9040540B2/en active Active
- 2012-11-09 JP JP2014540552A patent/JP6073910B2/ja active Active
-
2015
- 2015-04-22 US US14/693,307 patent/US9403797B2/en active Active
-
2016
- 2016-06-24 US US15/191,967 patent/US9765059B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014532751A5 (OSRAM) | ||
| RU2014147105A (ru) | 5-[[4-[[морфолин-2-ил]метиламино]-5-(трифторметил)-2-пиридил]амино]пиразин-2-карбонитрил, его терапевтические применения | |
| JP2015520753A5 (OSRAM) | ||
| ES2923875T3 (es) | Moduladores de la vía integrada del estrés | |
| JP6147799B2 (ja) | Ｐａｒｐインヒビターとの組合せ療法 | |
| JP2017036314A5 (OSRAM) | ||
| ES2911040T3 (es) | Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2) | |
| BR112020006780A2 (pt) | moduladores do estimulador de genes do interferon (sting) | |
| JP2021502388A (ja) | Ａｓｈ１ｌ阻害剤及びそれを用いた治療方法 | |
| ES3011282T3 (en) | Imidazo[4,5-c]pyridine derivatives as toll-like receptor agonsits | |
| TW201808914A (zh) | 整合應激途徑之調節劑 | |
| JP2016528246A5 (OSRAM) | ||
| JP2013512263A5 (OSRAM) | ||
| ES2862314T3 (es) | Compuestos de imidazo[1,2-a]piridina, composiciones que los comprenden, métodos para el tratamiento de enfermedades que los utilizan y métodos para prepararlos | |
| CN1276923C (zh) | 盐酸伊立替康的结晶多晶型物 | |
| BR112012033425A2 (pt) | pirazoloquinolinas | |
| JP2016504325A5 (OSRAM) | ||
| JP6978002B2 (ja) | チエノ−ピリミジン誘導体およびその使用 | |
| JP2021505600A (ja) | Ｎｓｄファミリー阻害物質及びそれによる治療の方法 | |
| CA2922542A1 (en) | Arylquinoline and analog compounds and use thereof to treat cancer | |
| AU2016298962A1 (en) | Compounds and pharmaceutical composition associated with ubiquitination-proteasome system | |
| RU2014121334A (ru) | Соединения 5-(пиридин-2-иламино)-пиразин-2-карбонитрила и их терапевтическое применение | |
| BR112020023866A2 (pt) | Agonistas de tlr7 | |
| WO2016115869A1 (zh) | Flt3激酶的新型抑制剂及其用途 | |
| JP6913955B2 (ja) | ＰＩ３Ｋ／ｍＴＯＲ阻害剤としての溶融キノリン化合物 |